| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/15/1993 | US5219985 Antifungal agent |
| 06/15/1993 | US5219886 Cardiovascular disorders, analgesics, enzyme inhibitors |
| 06/15/1993 | US5219851 Tetrahydroisoquinoline-type renin inhibiting peptides |
| 06/15/1993 | US5219838 Method for inhibiting tyrosinase activity in treatment of skin |
| 06/15/1993 | US5219837 Method of stimulating myelination of cells |
| 06/15/1993 | US5219739 Wound healing agents |
| 06/15/1993 | US5219738 Animal cell transformant, method for obtaining the transformant and method for producing desired foreign gene product by using the transformant |
| 06/15/1993 | US5219735 Non-phosphorylated peptides from casein-based material |
| 06/15/1993 | US5219579 Culture product of tumor tissue cells; cancer diagnosis, screening |
| 06/15/1993 | US5219578 Injecting immunoglobulin fraction obtained from serum of a goat free of artifically induced foreign antigens |
| 06/15/1993 | US5219577 Biologically active composition having a nanocrystalline core |
| 06/15/1993 | US5219576 Collagen wound healing matrices and process for their production |
| 06/15/1993 | US5219569 Protease resistant urokinase |
| 06/15/1993 | US5219568 Pharmaceutical composition for treating acute dysphonia |
| 06/15/1993 | US5219565 Treatment of primary cancers of the pleura |
| 06/15/1993 | US5219328 Fibrin sealant delivery method |
| 06/15/1993 | CA1319121C Cysteine proteinases, production and use |
| 06/15/1993 | CA1319106C Antacid composition |
| 06/15/1993 | CA1319099C Atriopeptins, guanylate cyclase activators, and phosphodiesterase inhibitors as treatment for glaucoma, hydrocephalus and cerebral edema (cranial fluid volume dysfunction) |
| 06/14/1993 | CA2085212A1 Nutritive composition for prevention and therapy of infection diseases caused by immunosuppression |
| 06/13/1993 | CA2085142A1 Stabilized pharmaceutical composition of non glycosyled recombinant human il2 in reduced form and preparation process therefore |
| 06/11/1993 | CA2084834A1 Proteins for inhibiting adhesion of platelets to collagen |
| 06/10/1993 | WO1993011280A1 Multiple solvent cleaning system |
| 06/10/1993 | WO1993011253A1 Cell-free ciliary neurotrophic factor/receptor complex |
| 06/10/1993 | WO1993011246A1 Novel proteases with dna fragmenting activity |
| 06/10/1993 | WO1993011239A1 New thrombin-inhibiting proteins from terrestrial leeches |
| 06/10/1993 | WO1993011238A1 Humanized b-b10, an anti-il2 receptor antibody |
| 06/10/1993 | WO1993011237A1 Cdr grafted humanised chimeric t-cell antibodies |
| 06/10/1993 | WO1993011235A1 Multimeric forms of members of the steroid/thyroid superfamily of receptors |
| 06/10/1993 | WO1993011234A1 Region of cytoplasmic domain of the human interleukin-4 receptor, as antagonists of il-4 |
| 06/10/1993 | WO1993011233A1 Dna fragment which codes for tumor cell proliferation inhibiting factor |
| 06/10/1993 | WO1993011232A1 Ifn-gamma antagonist cytokine |
| 06/10/1993 | WO1993011231A1 Tools for the diagnosis and treatment of alzheimer's disease |
| 06/10/1993 | WO1993011230A1 Modified mammalian stem cell blocking viral replication |
| 06/10/1993 | WO1993011229A1 Novel polypeptides for promoting cell attachment |
| 06/10/1993 | WO1993011223A1 Methods for production of purified soluble type b and type a human platelet-derived growth factor receptor fragments |
| 06/10/1993 | WO1993011222A1 Lipocortin-1 receptor protein and its uses |
| 06/10/1993 | WO1993011162A1 Bispecific antibody heterodimers |
| 06/10/1993 | WO1993011161A1 Multivalent antigen-binding proteins |
| 06/10/1993 | WO1993011160A1 Pharmaceutical composition containing anti-allergenic antibodies, method of purifying said antibodies and antibodies thus obtained |
| 06/10/1993 | WO1993011159A1 Human interleukin-8 analogs |
| 06/10/1993 | WO1993011156A1 Heparin- and sulfatide-binding peptides from the type i repeats of human thrombospondin |
| 06/10/1993 | WO1993011155A1 Fragments of prion proteins |
| 06/10/1993 | WO1993011154A1 Inhibitors of the conversion of big endothelin to endothelin |
| 06/10/1993 | WO1993011153A1 Peptides and antibodies for treatment of rheumatoid arthritis |
| 06/10/1993 | WO1993011152A1 New peptide derivatives |
| 06/10/1993 | WO1993011151A1 ALBOAGGREGINS: PLATELET AGONISTS WHICH BIND TO PLATELET MEMBRANE GLYCOPROTEIN Ib |
| 06/10/1993 | WO1993011147A1 Dna encoding a human 5-ht1e receptor and uses thereof |
| 06/10/1993 | WO1993011104A1 Organic salts of n, n'-diacetyl cystine |
| 06/10/1993 | WO1993010818A1 Infant formula and infant formula additives |
| 06/10/1993 | WO1993010817A1 CDw52-SPECIFIC ANTIBODY FOR TREATMENT OF MULTIPLE SCLEROSIS |
| 06/10/1993 | WO1993010816A1 Compositions for eliciting cytotoxic t-lymphocyte responses against viruses |
| 06/10/1993 | WO1993010813A1 Nucleotide and amino acid sequence of pemphigus vulgaris antigen and methods of use |
| 06/10/1993 | WO1993010812A1 Use of protease nexin-i as an antiinflammatory |
| 06/10/1993 | WO1993010811A1 Proteolytic mixture containing escharase and method of isolating same |
| 06/10/1993 | WO1993010810A1 Bone regeneration |
| 06/10/1993 | WO1993010809A1 Fibronectin-containing ophthalmic solution, method of manufacture of an ophthalmic solution, method of preserving an ophthalmic solution, and methods of treatment of ophthalmic wounds |
| 06/10/1993 | WO1993010808A1 INHIBITING TRANSFORMING GROWTH FACTOR β TO PREVENT ACCUMULATION OF EXTRACELLULAR MATRIX |
| 06/10/1993 | WO1993010807A1 Hemoregulatory peptides |
| 06/10/1993 | WO1993010806A1 Medicament for promoting growth of mammalian nerve |
| 06/10/1993 | WO1993010805A1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
| 06/10/1993 | WO1993010802A1 Aqueous synthetic organ extracts |
| 06/10/1993 | WO1993010800A1 Method of treating non-streptococcal bacterial infections |
| 06/10/1993 | WO1993010799A1 Method of treating viral infections |
| 06/10/1993 | WO1993010768A1 Pharmaceutically applicable nanosol and process for preparing the same |
| 06/10/1993 | WO1993010767A1 Peroral administration form for peptidic medicaments, in particular insulin |
| 06/10/1993 | WO1993010749A1 Hair modifier and hair care product, both containing antikeratinous antibody, and production of antikeratinous antibody |
| 06/10/1993 | WO1993010747A2 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING |
| 06/10/1993 | CA2125577A1 Use of protease nexin-i as an antiinflammatory |
| 06/10/1993 | CA2125298A1 Tools for the diagnosis and treatment of alzheimer's disease |
| 06/10/1993 | CA2124957A1 Methods for production of purified soluble type b and type a human platelet-derived growth factor receptor fragments |
| 06/10/1993 | CA2124948A1 Gamma ifn-antagonist cytokine |
| 06/10/1993 | CA2124691A1 Compositions for eliciting cytotoxic t-lymphocyte responses against viruses |
| 06/10/1993 | CA2124591A1 Inhibiting transforming growth factor .beta. to prevent accumulation of extracellular matrix |
| 06/10/1993 | CA2124461A1 Human interleukin-8 analogs |
| 06/10/1993 | CA2124358A1 Novel proteases with dna fragmenting activity |
| 06/10/1993 | CA2124338A1 Region of cytoplasmic domain of the human interleukin-4 receptor, as antagonists of il-4 |
| 06/10/1993 | CA2124202A1 Hemoregulatory peptides |
| 06/10/1993 | CA2123894A1 Bispecific antibody heterodimers |
| 06/10/1993 | CA2123803A1 Bone regeneration |
| 06/10/1993 | CA2123694A1 Peptides and antibodies for treatment of rheumatoid arthritis |
| 06/10/1993 | CA2123516A1 Organic salts of n,n'-diacetyl cystine |
| 06/10/1993 | CA2123207A1 Multiple solvent cleaning system |
| 06/10/1993 | CA2121800A1 Multimeric forms of members of the steroid/thyroid superfamily of receptors |
| 06/10/1993 | CA2121601A1 Novel thrombin-inhibitory proteins from terrestrial leeches |
| 06/10/1993 | CA2101162A1 Dna encoding a human 5-ht1e receptor and uses thereof |
| 06/10/1993 | CA2057288A1 Trophoblast interferon |
| 06/09/1993 | EP0545913A1 Delivery systems for pharmacological agents |
| 06/09/1993 | EP0545911A2 Lanthionine-containing bacteriocin compositions for use as bactericides |
| 06/09/1993 | EP0545772A1 Pharmaceutical composition containing EGF for treating bronchopulmonary pathologies |
| 06/09/1993 | EP0545343A1 Ligand-binding domains of fibroblast growth factor receptors and chimeric proteins containing these domains |
| 06/09/1993 | EP0545198A2 Peptides with insulin like activity |
| 06/09/1993 | EP0545194A1 Stable formulation of enalapril salt, a process for the preparation thereof and the use thereof |
| 06/09/1993 | EP0545147A2 Use of radical scavengers and/or substances suitable for deactivating nonradical reactive oxygen species for preventing or delaying human hair greying |
| 06/09/1993 | EP0545016A1 Composition for nucleic acid complex transfer in suspension eukaryotic cells |
| 06/09/1993 | EP0544942A1 Novel tools for the diagnosis and treatment of Alzheimer disease |
| 06/09/1993 | EP0544878A1 Asialoglycoprotein-conjugated medicinal agent |
| 06/09/1993 | EP0544860A1 Novel biologically active peptide compositions and uses therefor |
| 06/09/1993 | EP0544832A1 Recombinant bpi proteins, uses of bpi proteins, and methods of preparing same |
| 06/09/1993 | EP0544826A1 Superior thrombomodulin analogs for pharmaceutical use |